A67.1
Intermediate lesions of pinta
Clinical Classification Guidelines
Inclusion Terms
- Erythematous plaques of pinta
- Hyperchromic lesions of pinta
- Hyperkeratosis of pinta
- Pintids
Medical Intelligence & Overview
Intermediate lesions of Pinta, classified under ICD-10 code A67.1, refer to a middle stage in the progression of Pinta, a chronic bacterial infection caused by Treponema pallidum pertenue. This stage involves specific skin manifestations that indicate active infection and can be distinguished from early and late lesions. Recognizing these intermediate skin changes is important for diagnosis and understanding the disease’s progression. The key features include erythematous plaques, hyperchromic (darkened) lesions, hyperkeratosis, and pintids (small, pinpoint lesions). Understanding these aspects can help in identifying the disease early and managing it appropriately.
Causes & Symptoms
Clinical Causes: Infection with Treponema pallidum pertenue bacteria through direct contact with infected skin or lesions Persistent bacterial presence leading to skin inflammation and lesion formation Transmission often occurs in regions with poor sanitation and limited access to healthcare Environmental factors that facilitate the spread of infection, such as crowded living conditions
Key Symptoms: Erythematous plaques: Elevated, red patches of skin that may be slightly raised and inflamed Hyperchromic lesions: Darker patches of skin that develop as pigmentation changes occur during the disease’s course Hyperkeratosis: Thickening of the outer skin layer, resulting in rough, dry patches Pintids: Small, pinpoint-sized skin lesions that are often observed in the intermediate stage Possible mild itching or discomfort associated with skin changes Lesions often lack pain but can be persistent or recurrent during this stage
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a thorough skin examination to recognize characteristic plaques and hyperkeratotic lesions. Medical history, including exposure to endemic areas, is crucial. Laboratory tests such as skin smears, serologic tests, or biopsy may be used to confirm the presence of Treponema pallidum pertenue. Differential diagnosis may include other skin conditions with similar presentations, making clinical correlation essential.
Treatment Protocols: Treatment usually involves antibiotic therapy, primarily with penicillin or other appropriate antibiotics, to eradicate the infection. Managing skin lesions might include topical treatments to reduce inflammation or hyperkeratosis. Addressing environmental factors and preventing further transmission are also important aspects of care. Follow-up assessments are necessary to ensure resolution of lesions and monitor for potential recurrence.
Clinical Advice & FAQs
Billing Guidance
Is A67.1 a billable ICD-10 code?
Yes, A67.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A67.1?
Clinical documentation must specify the nature of Intermediate lesions of pinta and any associated comorbidities for accurate reporting.
Cite this Clinical Reference